IV drips used for "detoxification" actually filled with toxins; dozens poisoned
The IV drips included glutathione, which was not made to be injected.
Over three dozen individuals across four U.S. states have fallen victim to bacterial toxins in intravenous (IV) drips used for detoxification, as reported by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). The affected individuals ingested IV drips containing glutathione, a naturally occurring antioxidant with purported benefits such as detoxification, immune support, increased energy, and skin brightening.
Glutathione, a tripeptide found naturally within the body, has been studied for its potential therapeutic applications, although conclusive evidence-backed uses remain scarce. The U.S. Food and Drug Administration (FDA) has not approved any glutathione products for use as a drug. Despite this, glutathione is widely used as a dietary supplement, often marketed for its alleged benefits.
The issue, according to the CDC and FDA, lies in the production of IV drips by specialized drug manufacturers known as compounding pharmacies. These pharmacies create the IV drips using glutathione powders intended for oral consumption, a form of grading significantly different from that of purified glutathione used in sterile injectable drugs.
This discrepancy in drug grading has led to the dissemination of toxic IV drips, poisoning dozens of individuals who innocently sought wellness treatments at popular wellness clinics offering these IV drips.
Written by urgent.news from Ars Technica's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
